A media release from the Uniformed Services University of the Health Sciences last week announced the development of a highly specific assay for the detection of ERG oncoprotein. The assay is based on the development of an anti-ERG monoclonal antibody that appears to be capable of detecting the presence of ERG oncoprotein with > 99 percent accuracy. … READ MORE …
Filed under: Uncategorized | Tagged: ERG, monoclonal antibody, oncoprotein, test | Leave a comment »
In the continuing search for tests that will do a better job than the PSA test of defining clinically significant prostate cancer (as opposed to indolent disease) while it is still in its earliest possible stages, two new papers have provided information based on laboratory (not clinical studies). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: catenin, claudin, Diagnosis, ERG, risk, TMPRSS2 | 2 Comments »
Today’s news items deal with:
Filed under: Diagnosis, Risk, Uncategorized | Tagged: biopsy, dutasteride, ERG, laterality, PCA3, TMPRSS2 | 7 Comments »
Today’s news reports deal with such matters as:
Filed under: Drugs in development, Management, Treatment, Uncategorized | Tagged: abiraterone, androgen resistance, AT-101, CTC, ERG, mutation, radical prostatectomy | Leave a comment »
Today’s news reports cover items on:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: biopsy, CRPC, ERG, expression, gene, IMRT, PTEN, RALP, side effects, toxicity, urinary, voiding | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 